Results 201 to 210 of about 243,764 (341)

Antipsychotics and the Risk of Aspiration Pneumonia in Individuals Hospitalized for Nonpsychiatric Conditions: A Cohort Study

Journal of The American Geriatrics Society, 2017
S. Herzig, Mary T Lasalvia, Elliot Naidus, M. Rothberg, Wenxiao Zhou, J. Gurwitz, E. Marcantonio   +6 more
semanticscholar   +1 more source

Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison

, 2013
Daeyoung Roh, Jhin Goo Chang, Chan‐Hyung Kim, Hyun Sang Cho, Suk Kyoon An, Young‐Chul Jung   +5 more
openalex   +2 more sources

Childhood Maltreatment and Cognitive Functioning in Bipolar Disorder: A Systematic Review and Meta‐Analysis

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Aims Characterising the association between childhood maltreatment (CM) and cognitive functioning in bipolar disorder (BD) is crucial for improving the understanding of how early environmental risk factors impact the presentation of the disorder.
Natalia E. Fares‐Otero, Anaid Pérez‐Ramos, Ricardo Lopez‐Escribano, Sara Martin‐Parra, Luis Alameda, Sarah L. Halligan, Kamilla Woznica Miskowiak, Eduard Vieta   +7 more
wiley   +1 more source

Relative Effectiveness of Cognitive Behavior Therapy, Antipsychotics and the Combination for People with First Episode Psychosis: A Two-Study Pooled Analysis of Individual Participant Data. [PDF]

Schizophr Bull
Morrison AP, Pyle M, Law H, Emsley R, MacLennan G, Hudson J.   +5 more
europepmc   +1 more source

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

JAMA psychiatry, 2015
D. Maust, H. M. Kim, L. Seyfried, Claire Chiang, J. Kavanagh, L. Schneider, H. Kales   +6 more
semanticscholar   +1 more source

The Potential Role of Long-Acting Injectable Antipsychotics in People With Schizophrenia and Comorbid Substance Use

, 2012
Maju Mathew Koola, Heidi J. Wehring, Deanna L. Kelly   +2 more
openalex   +2 more sources

Neural Correlates of Cognitive Improvement After Virtual Reality‐Based Cognitive Remediation in Psychosis and Mood Disorders: A Randomized Controlled Trial

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Cognitive impairment in mood disorders and schizophrenia spectrum disorders hampers patients' clinical and functional outcomes. A key challenge in pro‐cognitive treatment development is the limited insight into the underlying neurocircuitry correlates of cognitive changes.
Viktoria Damgaard, Andreas Elleby Jespersen, Ida Kruse Søndergaard, Anders Lumbye, Maj Vinberg, Louise Birkedal Glenthøj, Merete Nordentoft, Anjali Sankar, Gitte Moos Knudsen, Julian Macoveanu, Kamilla Woznica Miskowiak   +10 more
wiley   +1 more source

Antipsychotic load during olanzapine mono- versus polytherapy and in relation to age. [PDF]

Eur J Clin Pharmacol
Solhaug V, Waade RB, Jansrud L, Molden E, Størset E, Høiseth G, Tveito M.   +6 more
europepmc   +1 more source

Cognitive and Psychomotor Processing Speed in Medication‐Naïve Individuals With First‐Episode of Psychosis: The Role of Peripheral Inflammatory Markers

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background and Hypothesis Deficits in processing speed (PS) and psychomotor speed (PMS) are core cognitive impairments in schizophrenia spectrum disorders, including first‐episode psychosis (FEP). Neuroinflammation has been proposed as a potential contributor to these deficits.
Ángel Yorca‐Ruiz, Carlos Martínez Asensi, Rebeca Magdaleno Herrero, Alexandre Díaz‐Pons, Víctor Ortiz‐García de la Foz, Luis Manuel Fernández Cacho, Ana Catalán Alcantara, Benedicto Crespo‐Facorro, Rosa Ayesa‐Arriola   +8 more
wiley   +1 more source

Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized? [PDF]

Schizophr Bull
Krivoy A, Tiihonen J, Nissan J, Dotan A, Arnheim D, Menkes-Caspi N, Taub S, Tuppurainen H, Mittendorfer-Rutz E, Davidson M, Davis JM, Weiser M, Taipale H.   +12 more
europepmc   +1 more source